1. Badertscher A, Bauersfeld U, Arbenz U, Baumgartner MR, Schinzel A, Balmer C. Cardiomyopathy in newborns and infants: a broad spectrum of aetiologies and poor prognosis. Acta Paediatr. 2008. 97:1523–1528.
2. Oh JH, Hong YM, Choi JY, et al. Idiopathic cardiomyopathies in Korean children. - 9-Year Korean Multicenter Study -. Circ J. 2011. 75:2228–2234.
3. Fahrner JA, Frazier A, Bachir S, et al. A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1. Am J Med Genet A. 2012. 158A:1414–1421.
4. Berger S, Dhala A, Dearani JA. State-of-the-art management of hypertrophic cardiomyopathy in children. Cardiol Young. 2009. 19:Suppl 2. 66–73.
5. Eidem BW, Jones C, Cetta F. Unusual association of hypertrophic cardiomyopathy with complete atrioventricular canal defect and Down syndrome. Tex Heart Inst J. 2000. 27:289–291.
6. Somerville J, Becú L. Congenital heart disease associated with hypertrophic cardiomyopathy. Br Heart J. 1978. 40:1034–1039.
7. Kim WW, Shim SH. A case report of Noonan syndrome with mental retardation and attention-deficit hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry. 2012. 23:31–35.
8. Kim J, Kim MR, Kim HJ, Lee KA, Lee MG. LEOPARD Syndrome with PTPN11 Gene Mutation Showing Six Cardinal Symptoms of LEOPARD. Ann Dermatol. 2011. 23:232–235.
9. Kim JY, Kim MJ, Song ES, Jho YK, Choi YY, Ma JS. Costello syndrome: three sporadic cases. Korean J Pediatr. 2007. 50:1024–1029.